// App-Quantinova.ai

4036 : Efficacy and safety of rhLT-Da with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-labelled, controlled, phase IIb trial.

Researchers

Presenter

  • Yu-hong Li

Principal Investigators

  • Wenqi Jiang

  • Fenghua Wang

  • Guo-ping Sun

  • Jianhua Chen

  • Lin Ying Cheng

  • Wei Liu

  • Rong-sheng Zheng

  • Jia Chen

  • Helong Zhang

  • Hai-tao Lan

  • Jun Qi

  • Yang-qing Liu

  • Yan-ming Deng

  • Heng Zhao

  • Jian ping Xiong

  • Qing Xu

Medical Centers

  • Department of Breast Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China

  • State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

  • Department of Oncology, The First Affiliated Hospital of An Hui Medical University, Hefei, China

  • Hunan Cancer Hospital, Changsha, China

  • Cancer Hospital of Shantou University Medical College, Shantou, China

  • Breast canter, Fourth Hospital of Hebei Medical University, Shijiazhuang, China

  • Anhui Provincial Cancer Hospital, Hefei, China

  • Jiangsu Cancer Hospital, Nanjing, China

  • Xijing Hospital, The Fourth Military Medical University, Xi'an, China

  • Sichuan Provincial People's Hospital, Chengdu, China

  • Chongqing Cancer Hospital, Chongqing, China

  • Huai'an First People's Hospital, Huaian, China

  • The First People's Hospital, Foshan City, Foshan, China

  • Shanghai Jiaotong University, Shanghai, China

  • The First Affiliated Hospital of Nanchang University, Nanchang, China

  • Shanghai the 6th Peoples Hospital, Shanghai, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal squamous carcinoma cell

Biomarkers

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Fluorouracil

  • Adrucil injection

  • Cisplatin

Outcome

  • N/A


Study Design

  • Randomized

  • Multicenteric

  • Controlled

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final